Lucrezia Pignatti

Lucrezia Pignatti

Auto-generated profile, based on publicly available information

Lucrezia Pignatti

Department of Mother Infant, Obstetrics and Gynecology Unit, University of Modena and Reggio Emilia, Modena, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2013 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Open access
EPE. Petrella
E. Petrella
MMM. Malavolti
M. Malavolti
VBV. Bertarini
V. Bertarini
LPL. Pignatti
L. Pignatti
INIsabella Neri
Isabella Neri
FFfabio Facchinetti
fabio Facchinetti
To determine whether changes in lifestyle in women with BMI > 25 could decrease gestational weight gain and unfavorable pregnancy outcomes. Women with BMI > 25 were randomized at 1st trimester to no intervention or a Therapeutic Lifestyle Changes (TLC) Program including diet (overweight: 1700 kcal/day, obese: 1800 kcal/day) and mild physical activity (30 min/day, 3 times/week). At baseline and at the 36th week women filled-in a Food Frequency Questionnaire. gestational weight gain, gestational diabetes mellitus, gestational hypertension, preterm delivery. Data stratified by BMI categories. Socio-demographic features were similar between groups (TLC: 33 cases, 28 cases). At term, gestational weight gain in obese women randomized to TLC group was lower (6.7 ± 4.3 kg) versus controls (10.1 ± 5.6 kg, p = 0.047). Gestational diabetes mellitus, gestational hypertension and preterm delivery were also significantly lower. TLC was an independent factor in preventing gestational weight gain, gestational diabetes mellitus, gestational hypertension. Significant changes in eating habits occurred in the TLC group, which increased the number of snacks, the intake of fruits-vegetables and decreased the consumption of sugar. A caloric restriction associated to changes in eating behavior and constant physical activity, is able to reduce gestational weight gain and related pregnancy complications in obese women.

1 July 2017 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
FFFabio Facchinetti
Fabio Facchinetti
PVPatrizia Vergani
Patrizia Vergani
MTMariarosaria Di Tommaso
Mariarosaria Di Tommaso
LMLuca Marozio
Luca Marozio
BABarbara Acaia
Barbara Acaia
OGon behalf of the PROTECT Collaborative Group
on behalf of the PROTECT Collaborative Group
To assess the efficacy of progestogens for maintenance tocolysis in women undelivered after their first preterm labor episode. Women with singleton pregnancies between 22 0/7 and 31 6/7 weeks of gestation with arrested preterm labor and a cervical length 25 mm or less at hospital discharge were eligible. Patients with a previous preterm birth were excluded. In a randomized controlled trial conducted in five university hospitals, women were randomized to receive vaginal progesterone (200 mg per day) or intramuscular 17α-hydroxyprogesterone caproate (341 mg per week) or to an observation groups (control group). The primary outcome was the proportion of women with preterm birth at less than 37 weeks of gestation. A sample size of 160 per group (n=480) was planned to compare vaginal progesterone and 17α-hydroxyprogesterone caproate groups with those in the control group. The sample size estimation was based on the hypothesis that the risk of experiencing preterm birth in the control group would be 30% and that 17α-hydroxyprogesterone caproate or progesterone would decrease this risk to 15%. A P value of <.025 was defined as statistically significant. At planned interim analysis (n=254), the trial was stopped for futility. Between July 2010 and June 2015, 257 women were eligible and 254 were subsequently randomly assigned to vaginal progesterone (n=86), 17α-hydroxyprogesterone caproate (n=87), or observation (n=81). Nineteen (8%) were excluded from the analysis because they either dropped out or information was missing, leaving 235 women available for analysis. Demographic characteristics were similar across groups. The preterm birth rate did not differ significantly between groups: 23% in the 17α-hydroxyprogesterone caproate group, 39% in the vaginal progesterone group, and 22% in the women in the control group (P=.949 for 17α-hydroxyprogesterone caproate compared with the women in the control group and P=.027 for vaginal progesterone compared with women in the control group). The use of progestogens for maintenance tocolysis in women with a short cervix did not reduce the rate of preterm birth. ClinicalTrials.gov, NCT01178788.

26 October 2016 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Open access
Giovanni GrandiGiovanni Grandi
Giovanni Grandi
LPLucrezia Pignatti
Lucrezia Pignatti
FFFrancesca Ferrari
Francesca Ferrari
GDGiulia Dante
Giulia Dante
INIsabella Neri
Isabella Neri
FFFabio Facchinetti
Fabio Facchinetti
Inflammation might be an important underlying cause of preterm birth. Our aim is to explore whether vaginal administration α-lipoic acid reduces cervical inflammation and shortening after primary tocolysis. Singleton pregnancies between 24-30 weeks remaining undelivered after hospitalization for preterm labor were randomly allocated to placebo (20 women, 15 analyzed) or vaginal ALA 400 mg (active ingredient 10 mg) daily (20 women, 17 analyzed) for 30 days. A cervical swab to quantify pro-inflammatory (IL1, IL2, IL6, IL8, TNFα) and anti-inflammatory (IL4, IL10) cytokines as well as transvaginal ultrasound cervical length measurement (CL) were performed before and after treatment. The % changes of pro-inflammatory cytokines do not differ between treatment groups, while IL4 significantly increases by vaginal ALA in comparison to placebo (118.0 ± 364.3% versus 29.9 ± 103.5%, p = 0.012). Combined anti-inflammatory cytokines show same trend (292.5 ± 208.5% versus 64.5 ± 107.4, p = 0.03). CL remains similar in vaginal ALA group (from 23.1 ± 6.6 to 20.80 ± 7.9 mm), while it significantly decreased in placebo group (from 20.4 ± 6.5 to 13.8 ± 7.5 mm, p < 0.001 versus Baseline; p = 0.003 versus vaginal ALA). Vaginal ALA significantly stimulates anti-inflammatory ILs in the cervix of undelivered women after a preterm labor episode. This effect is associated with a stabilization of the CL.

1 April 2014 in Pregnancy Hypertension
Verified
Journal Article
Open access
EPElisabetta Petrella
Elisabetta Petrella
LPLucrezia Pignatti
Lucrezia Pignatti
INIsabella Neri
Isabella Neri
FFfabio Facchinetti
fabio Facchinetti
To evaluate the l-arginine/NO system and its role in insulin signaling and endothelial function during the pregnancy of women of different BMI categories. Twelve women with BMI⩾25 were compared with 10 normal-weight women in a fasting condition after the infusion of l-arginine (20g in 3h) and after the evaluation of the flow-mediated vasodilation (FMD) of the brachial artery between the 9th-12th and 24th-27th weeks. Blood samples for insulin and nitrite/nitrate (NOx) were collected at baseline and after 1, 2 and 3h after initiating the infusion. In both trimesters, the baseline NOx levels were similar among groups. In the 1st trimester of the lean women, there was a NOx increase in response to l-Arg (AUC: 1328; 3, 3173), which had increased by the 2nd trimester (AUC: 3884; 1905, 7686); in overweight/obese women, no responses to l-Arg were found in the 1st or 2nd trimesters. In the 1st trimester, the insulin levels were significantly reduced in both groups after l-Arg infusion. Although the insulin levels in all BMI categories were higher in the 2nd trimester, such levels during weeks 24-27 were suppressed only in normal-weight women after l-Arg infusion. The FMD was higher during both trimesters in the lean controls and was impaired in the overweight/obese subjects. NO availability is impaired in overweight/obese women during pregnancy, which affects endothelial functioning and interferes with insulin regulation. These mechanisms could be involved in the development of hypertensive disorders and glucose intolerance in this population.

1 January 2018 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
INIsabella Neri
Isabella Neri
GDGiulia Dante
Giulia Dante
LPLucrezia Pignatti
Lucrezia Pignatti
CSChiara Salvioli
Chiara Salvioli
FFFabio Facchinetti
Fabio Facchinetti
Purpose: The aim of this study is to investigate the safety and efficacy of castor oil to induce labour.Materials and methods: A retrospective observational case control study was conducted over five years. Castor oil was proposed to women referred to the Birth Centre (Castor Oil group (COG)). They were compared to women who chose to be followed by the traditional doctor-led unit (control group (CG)). Castor oil was administered in a 60ml single dose in 200ml of warm water. Inclusion criteria were gestational age between 40 and 41 weeks plus premature rupture of membranes between 12 and 18hours or amniotic fluid index4 or Bishop Score of 4 or absence of spontaneous labour over 41+4 weeks.Results: Pharmacological induction of labour was required for 18 women in the COG (45%) and 36 in the CG (90%) (p<.001). The mode of delivery differed significantly between groups: women assuming castor oil showed a higher incidence of vaginal delivery, whereas the incidence of caesarean section was lower in the COG, but no statistical significance was reached.Conclusions: The use of castor oil is related to a higher probability of labour initiation within 24hours. Castor oil can be considered a safe non-pharmacological method for labour induction.

1 August 2019 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Closed access
FFfabio Facchinetti
fabio Facchinetti
VVVidisha Vijai
Vidisha Vijai
EPElisabetta Petrella
Elisabetta Petrella
SZSofia Gambigliani Zoccoli
Sofia Gambigliani Zoccoli
LPLucrezia Pignatti
Lucrezia Pignatti
INIsabella Neri
Isabella Neri